Search filters

List of works by Saad Shakir

A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes

scientific article published on 18 November 2011

A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England

scientific article published in September 2002

An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making

scientific article

Challenges for Drug Repurposing in the COVID-19 Pandemic Era

scientific article published on 06 November 2020

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia

scientific article published on 06 June 2012

Developing tools for the safety specification in risk management plans: lessons learned from a pilot project

scientific article published on May 2008

European commission consultation on pharmacovigilance

scientific article published on 01 February 2008

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

scientific article published on 03 November 2020

Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project

scientific article published on 26 December 2016

Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes

scientific article published in August 2006

Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes

scientific article (publication date: 2013)

Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database

scientific article

How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme

scientific article published in March 2013

How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine

scientific article published on 21 November 2020

Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study

scientific article

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

scientific article published on 09 October 2020

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes

scientific article

Investigation assessing the publicly available evidence supporting postmarketing withdrawals, revocations and suspensions of marketing authorisations in the EU since 2012.

scientific article

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

scientific article published on 23 June 2020

New Postgraduate Qualifications in Pharmacovigilance from the Drug Safety Research Unit in the UK

scientific article published on January 1, 2011

Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in England

scientific article published on September 2010

Paediatric post‐marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults ⬇️

scientific article published on February 23, 2011

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

scientific article published on 21 October 2020

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

scientific article published in March 2005

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

scientific article published in April 2005

Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice

scientific article published on 23 July 2020

Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites

scientific article published on 04 November 2020

Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England

scientific article

Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment

scientific article published on 28 May 2020

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

scientific article published on 21 January 2016

Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study

scientific article published on April 2013

The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK

scientific article published on 01 March 2020

The safety of H1N1 vaccine in children in Saudi Arabia: a cohort study using modern technology in a developing country

scientific article published in July 2012

Paulina is supported by:

About Paulina

Help